Risk for malignant lymphoma in ankylosing spondylitis: a nationwide Swedish case-control study
about
Autoimmune/Inflammatory Arthritis Associated Lymphomas: Who Is at Risk?Ankylosing spondylitis, psoriatic arthritis, and risk of malignant lymphoma: a cohort study based on nationwide prospectively recorded data from Sweden.Case definitions in Swedish register data to identify systemic lupus erythematosus.Diagnostic Prevalence of Ankylosing Spondylitis Using Computerized Health Care Data, 1996 to 2009: Underrecognition in a US Health Care SettingNon-Hodgkin's lymphoma following treatment with etanercept in ankylosing spondylitis.Ankylosing spondylitis patients commencing biologic therapy have high baseline levels of comorbidity: a report from the Australian rheumatology association database.Risk of malignancy in ankylosing spondylitis: a systematic review and meta-analysis.Treatment of ankylosing spondylitis: focus on etanercept.Nucleoside diphosphate kinase/Nm23 and Epstein-Barr virus.Malignancy as a comorbidity in rheumatic diseases.Spinal non-Hodgkin's lymphoma mimicking a flare of disease in a patient with ankylosing spondylitis treated with anti-TNF agents: case report and review of the literature.Management of ankylosing spondylitis with infliximab.Prevalence of comorbidities and evaluation of their screening in spondyloarthritis: results of the international cross-sectional ASAS-COMOSPA study.Mortality in ankylosing spondylitis: results from a nationwide population-based study.Increased risk of cancer for patients with ankylosing spondylitis: a nationwide population-based retrospective cohort study.Comorbidities in Spondyloarthritis.
P2860
Q26739361-76BB5143-E5C1-4A36-9204-DBE275E2732AQ30811500-DBE6EB33-3DC4-4DAB-828C-1EC4EBE3F427Q31034949-857D4035-E1F4-4676-B279-36DC5677C03BQ31118921-723AF716-B694-4D0C-BFC4-36008CB85C60Q33387555-BE7BDB36-60C3-4911-847F-2E633361A204Q33602465-824D9D6D-B2B3-4BA6-B7CA-56D24F80330DQ36106183-040EB73D-E5F2-4714-B10A-08EB5F93F92CQ37290601-D9C0B66F-E935-4E18-A0F3-7E7C1089079FQ37468665-9E83927E-87B5-49E0-8A52-7987E01455DFQ38029322-9257C68B-0A27-4BDB-9BDF-A8DB8611D530Q38202031-B9404DBB-60B7-40BF-AF7F-394B078F5E63Q38993236-6C283B0D-B3BA-48A5-A5F4-F26668B9536BQ40405924-464B3881-116F-4FCC-987F-2D7EDAE0BC74Q41016710-BC43F949-272C-4427-B652-599E529A8EE7Q43503507-6DCB324B-C9E5-4100-915B-4D3CD5F81EB0Q54246292-0F53DB53-FB17-4C7D-A3E3-1B82448416A3
P2860
Risk for malignant lymphoma in ankylosing spondylitis: a nationwide Swedish case-control study
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Risk for malignant lymphoma in ...... ide Swedish case-control study
@ast
Risk for malignant lymphoma in ...... ide Swedish case-control study
@en
type
label
Risk for malignant lymphoma in ...... ide Swedish case-control study
@ast
Risk for malignant lymphoma in ...... ide Swedish case-control study
@en
prefLabel
Risk for malignant lymphoma in ...... ide Swedish case-control study
@ast
Risk for malignant lymphoma in ...... ide Swedish case-control study
@en
P2093
P2860
P356
P1476
Risk for malignant lymphoma in ...... ide Swedish case-control study
@en
P2093
P2860
P304
P356
10.1136/ARD.2005.047514
P407
P577
2006-01-13T00:00:00Z